Date | Filer | Title | Filing | Type | Shares Traded | Price | Total Held |
---|---|---|---|---|---|---|---|
May 16, 2023 |
Director, President and CEO
Trans History: 29
|
Director, President and CEO | Form 4 | Other acquisition or disposition | -- | -- | 5,025 |
May 16, 2023 |
Director, President and CEO
Trans History: 29
|
Director, President and CEO | Form 4 | Other acquisition or disposition | -- | -- | 5,025 |
Mar 06, 2023 |
General Counsel
Trans History: 4
|
General Counsel | Form 3 | Initial Statement of Beneficial Ownership of Securities | -- | -- | 39,270 |
Feb 17, 2023 |
Director, President and CEO
Trans History: 29
|
Director, President and CEO | Form 4 | Other acquisition or disposition | -- | -- | 5,025 |
May 16, 2022 |
Director, President and CEO
Trans History: 29
|
Director, President and CEO | Form 4 | Other acquisition or disposition | -- | -- | 5,025 |
Feb 22, 2022 |
Director
Trans History: 3
|
Director | Form 3 | Initial Statement of Beneficial Ownership of Securities | -- | -- | -- |
Dec 01, 2021 |
Director, President and CEO
Trans History: 29
|
Director, President and CEO | Form 4 | Other acquisition or disposition | -- | -- | 585,191 |
Jun 15, 2021 |
Chief Business Officer
Trans History: 2
|
Chief Business Officer | Form 3 | Initial Statement of Beneficial Ownership of Securities | -- | -- | -- |
Jun 08, 2021 |
Chief Commercial Officer
Trans History: 2
|
Chief Commercial Officer | Form 3 | Initial Statement of Beneficial Ownership of Securities | -- | -- | -- |
Sep 03, 2020 |
Chief Medical Officer
Trans History: 12
|
Chief Medical Officer | Form 3 | Initial Statement of Beneficial Ownership of Securities | -- | -- | -- |
* Represents the number of non-derivative securities directly held. (I) Indicates that some (or all) of these shares are held indirectly.